Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Embeda in Children with Moderate-to-Severe Pain
NCT02101554Phase 4Terminated
- Sponsor
- Pfizer
- Start
- Apr 2015
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Embeda in pain, sponsored by Pfizer. Started Apr 2015; status: terminated.
02
Drugs
Embeda
03
Conditions
pain
Beyond the preview
Go deeper on NCT02101554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02101554.